- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: rituximab [MabThera/Rituxan]
Total 3381 results
-
Pharmacyclics LLC.Janssen Research & Development, LLCCompletedWaldenström's MacroglobulinemiaUnited States, Spain, France, Canada, Germany, Italy, Australia, United Kingdom, Greece
-
M.D. Anderson Cancer CenterPharmacyclics LLC.Completed
-
University of LouisvilleJames Graham Brown Cancer CenterTerminatedLymphoma, Small Lymphocytic | Leukemia, Lymphocytic, ChronicUnited States
-
M.D. Anderson Cancer CenterGenentech, Inc.Completed
-
PharmatechCephalonCompletedDiffuse Large B-Cell LymphomaUnited States
-
Haukeland University HospitalOslo University Hospital; University Hospital of North Norway; Helse Stavanger... and other collaboratorsActive, not recruitingRelapsing Remitting Multiple SclerosisNorway, Sweden
-
JHL Biotech, Inc.TerminatedArthritis, Rheumatoid | Rheumatoid ArthritisBosnia and Herzegovina, Bulgaria, Czechia, Germany, Hungary, Lithuania, Poland, Russian Federation, Taiwan, Ukraine, United Kingdom
-
Nantes University HospitalHoffmann-La Roche; French Innovative Leukemia OrganisationCompletedB-Cell LymphomaFrance
-
UNC Lineberger Comprehensive Cancer CenterNational Cancer Institute (NCI)Completed
-
National Cancer Institute (NCI)RecruitingNodular Lymphocyte Predominant B-Cell Lymphoma | Recurrent Nodular Lymphocyte Predominant B-Cell Lymphoma | Refractory Nodular Lymphocyte Predominant B-Cell LymphomaUnited States
-
Dana-Farber Cancer InstituteMillennium Pharmaceuticals, Inc.CompletedWaldenstrom's MacroglobulinemiaUnited States
-
Newcastle-upon-Tyne Hospitals NHS TrustNewcastle University; National Institute for Health Research, United Kingdom; Department of Health, United KingdomCompletedFatigue | Primary Biliary CirrhosisUnited Kingdom
-
Northwestern UniversityBayerCompletedLeukemiaUnited States
-
Hoffmann-La RocheTerminatedDiffuse Large B-Cell LymphomaRomania
-
Chronic Lymphocytic Leukemia Research ConsortiumCelgene CorporationUnknownChronic Lymphocytic Leukemia | CLL | Untreated | First-Line | Front-line | Initial TherapyUnited States
-
National Cancer Institute (NCI)TerminatedExtranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Recurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular Lymphoma | Recurrent Grade 3 Follicular Lymphoma | Recurrent Marginal Zone Lymphoma | Splenic Marginal Zone... and other conditionsUnited States
-
Hoffmann-La RocheCompletedLymphocytic Leukemia, ChronicAustralia, Brazil, Spain, Italy, Canada, Germany, Chile, Mexico, France, Argentina, Croatia, Russian Federation, Slovakia, Turkey, Poland, Czechia, New Zealand, Portugal, Greece
-
Medical University of ViennaRecruitingMantle-cell LymphomaAustria
-
Centre Hospitalier Universitaire de Saint EtienneMinistry of Health, FranceRecruiting
-
Juan P. Alderuccio, MDADC Therapeutics S.A.RecruitingFollicular LymphomaUnited States
-
BeiGeneRecruitingMarginal Zone Lymphoma | Relapsed/Refractory Follicular LymphomaUnited States, Italy, Spain, China, United Kingdom, Australia, Israel, Korea, Republic of, Belgium, France, Brazil, Ireland, Czechia, Romania, Portugal, Georgia, Argentina, Poland, Puerto Rico, Austria, Switzerland
-
Hoffmann-La RocheActive, not recruitingChronic Lymphocytic Leukemia (CLL)United States, Italy, Australia, Spain, France
-
Hoffmann-La RocheBiogenCompletedRheumatoid ArthritisBelgium, France, Germany, Norway, United Kingdom, United States, Ireland, Canada, Israel, Netherlands, Italy
-
National Cancer Institute (NCI)CompletedRecurrent Adult Burkitt Lymphoma | Recurrent Adult Diffuse Large Cell Lymphoma | Recurrent Adult Diffuse Mixed Cell Lymphoma | Recurrent Adult Diffuse Small Cleaved Cell Lymphoma | Recurrent Adult Lymphoblastic Lymphoma | Recurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular Lymphoma and other conditionsUnited States
-
Nathan DenlingerBristol-Myers SquibbRecruitingB-Cell Non-Hodgkin Lymphoma-Recurrent | Diffuse Large B-Cell Lymphoma-Recurrent | Follicular Lymphoma-Recurrent | High Grade B-Cell Lymphoma-Recurrent | Primary Mediastinal Large B-Cell Lymphoma-Recurrent | Transformed Indolent B-Cell Non-Hodgkin Lymphoma to Diffuse Large B-Cell Lymphoma-Recurrent and other conditionsUnited States
-
Loxo Oncology, Inc.Eli Lilly and CompanyActive, not recruitingChronic Lymphocytic Leukemia | Small Lymphocytic LymphomaChina, United States, Spain, Belgium, Austria, Czechia, Australia, Italy, Japan, Hungary, United Kingdom, Taiwan, Turkey, Germany, Canada, France, Israel, Poland, Croatia, Korea, Republic of, Ireland, Russian Federation, Singapore, Sw...
-
Loxo Oncology, Inc.Eli Lilly and CompanyActive, not recruitingChronic Lymphocytic Leukemia | Small Lymphocytic LymphomaChina, Spain, Czechia, Taiwan, Italy, Japan, New Zealand, Poland, Hungary, United States, United Kingdom, Australia, Romania, Portugal, Korea, Republic of, Russian Federation, Austria, Brazil, Bulgaria, France, Ireland
-
Fudan UniversityTerminated
-
Hamilton Health Sciences CorporationHoffmann-La Roche; McMaster University; Canadian Apheresis GroupUnknownThrombotic Thrombocytopenic Purpura | Hemolytic Uremic SyndromeCanada
-
Chinese University of Hong KongCompleted
-
Fredrik PiehlUnknownA Study Evaluating the Safety and Efficacy of Rituximab in Patients With Myasthenia Gravis (Rinomax)Generalized Myasthenia GravisSweden
-
M.D. Anderson Cancer CenterBiogenCompletedLymphoma | Non-Hodgkin's LymphomaUnited States
-
M.D. Anderson Cancer CenterBayerCompletedChronic Lymphocytic LeukemiaUnited States
-
Swedish Medical CenterGenentech, Inc.Completed
-
Merck Sharp & Dohme LLCCompletedChronic Lymphocytic Leukemia | Small Lymphocytic Lymphoma
-
HealthCore-NERINational Heart, Lung, and Blood Institute (NHLBI); Genentech, Inc.TerminatedThrombotic Thrombocytopenic PurpuraUnited States
-
Emory UniversityGenentech, Inc.Active, not recruitingStage IV Skin Melanoma | Stage IIIB Skin Melanoma | Stage IIIC Skin Melanoma | Unresectable Melanoma | Stage III Melanoma | Stage IIIA Skin Melanoma | Cutaneous Melanoma, Stage III | Cutaneous Melanoma, Stage IVUnited States
-
Sidney Kimmel Comprehensive Cancer Center at Johns...National Cancer Institute (NCI)CompletedMultiple Myeloma and Plasma Cell NeoplasmUnited States
-
Dana-Farber Cancer InstituteRecruitingChronic Lymphocytic Leukemia | Small Lymphocytic LymphomaUnited States
-
Mehrdad Abedi, MDNational Cancer Institute (NCI)RecruitingRecurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell LymphomaUnited States
-
University of GiessenCompletedMarginal Zone Lymphomas | Non-Hodgkin Lymphomas | Follicular Lymphomas | Immunocytomas | Lymphocytic LymphomasGermany
-
National Cancer Institute (NCI)Active, not recruitingAnemia | Chronic Lymphocytic Leukemia | Small Lymphocytic LymphomaUnited States
-
Fred Hutchinson Cancer CenterTerminatedDiffuse Large B-Cell Lymphoma | Burkitt Lymphoma | KSHV-associated Multicentric Castleman DiseaseUganda
-
Incyte CorporationWithdrawn
-
Ohio State University Comprehensive Cancer CenterCompletedNon-Hodgkin's Lymphoma | Mantle Cell LymphomaUnited States
-
Grupo Español de Linfomas y Transplante Autólogo...Completed
-
M.D. Anderson Cancer CenterBiogen; CTI BioPharmaCompleted
-
M.D. Anderson Cancer CenterGenzyme, a Sanofi CompanyTerminated
-
Jonsson Comprehensive Cancer CenterNational Cancer Institute (NCI); Genentech, Inc.Completed
-
Massachusetts General HospitalDana-Farber Cancer Institute; Beth Israel Deaconess Medical CenterTerminatedDiffuse Large B Cell LymphomaUnited States